Industry Experts – Market Research Reports

Industry Experts caters the market research needs of a broad range of industry verticals comprising Automotive, Healthcare, Food & Beverage, Telecom & Internet, Chemicals & Plastics, Biotechnology and Consumer Goods. The company also provides customized market research and industry analysis services for a wide range of industry sectors.

15 Jul

Biopharmaceuticals Global Market to Grow by Robust 13.5% (2010-2020) to Reach $498 Billion by 2020

Posted in Biotechnology, News on 15.07.13 by IE Admin

Industry Experts, a multi industry focused market research firm, has unveiled the 2013 version of ‘Biopharmaceuticals – A Global Market Overview’. As per the new report monoclonal antibodies (moAb) constitutes the largest product segment in the global biopharmaceuticals market accounting for an estimated share of 25.6% in 2013, equating to US$51.1 billion. In addition, monoclonal antibodies (moAb) are forecasted to record fastest growth in reaching US$138.8 billion by 2020 at a 2010-20 CAGR of 14.9%.
The pharmaceutical R&D pipeline and industry have been witnessing greater degree of dependence on biopharmaceuticals. Development of these products is being undertaken by a growing number of players in the pharmaceutical industry, which include the big pharma companies as also generic drug manufacturers, who are also engaged in developing biosimilars. In conjunction with the traditional small biopharmaceutical companies, the new bigger entrants have been focused on continually expanding the global biologics pipeline, implying that the number and proportion of new pharmaceuticals being commercialized would increasingly comprise biopharmaceuticals and not small molecule drugs. As the cost of developing biopharmaceuticals and bringing them to market is generally much higher, offering enhanced profit margins, it comes as no surprise that the global pharmaceutical industry would continue to rely on biopharmaceuticals for profits and innovation, in addition to its very survival.
Even though the worldwide economic recession has been slow in recovering, the global pharmaceutical and biopharmaceutical industries have marched ahead, showing profitability and growth. According to estimates, more than 10k therapeutics are currently in the research and development stage, which include chemical substance pharmaceuticals or drugs and biotechnology-derived pharmaceuticals or biopharmaceuticals undergoing over 40k clinical trials. This translates into a significant increase from as little as half-a-decade back, indicating a conspicuous shift in the pharmaceutical industry from developing small molecule drugs to biopharmaceuticals for obtaining novel, ground-breaking and profitable solutions.
The report reviews, analyses and projects the biopharmaceuticals market (2010-2020) for global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 14 independent countries across North America – The United States, Canada and Mexico; Europe – Germany, the United Kingdom, France, Italy, Spain and Russia; Asia-Pacific – Japan, China and India; South America – Argentina and Brazil.
Biopharmaceuticals product segments analyzed in this study comprises Monoclonal Antibodies (moAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Human Growth Hormones (HGH) and others. Therapeutic areas analyzed include Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular and others. Biopharmaceuticals market, estimated at US$199.7 billion globally in 2013, is further projected to reach US$497.9 billion by 2020, growing at 13.5% CAGR between 2010 and 2020. Among different product segments, monoclonal antibodies (moAb) constitutes the largest product segment in the global biopharmaceuticals market accounting for an estimated share of 25.6% in 2013, equating to US$51.1 billion. In terms of therapeutic area, neurology applications is the largest market for global biopharmaceuticals with an estimated 2013 share of 28.2% valued at US$56.3 billion, and further expected reach a projected US$144.5 billion by 2020.
The study includes 249 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market by geographic region, product segment and therapeutic area. This study profiles 25 key global players and 70 major players across North America – 24; Europe – 17; Asia-Pacific – 27 and Rest of World – 2. The report also provides the listing of the companies engaged in research and development, manufacturing and supply of biopharmaceuticals. The global list of companies covers addresses, contact numbers and the website addresses of 492 companies.

For more details, please visit http://industry-experts.com/verticals/biotechnology/biopharmaceuticals-a-global-market-overview.html

tags: , , , , , ,

56 Comments »

08 Jul

Global Synthetic Vitamin-E Market to Touch $1600 Million by 2020

Posted in General Reports, News on 08.07.13 by IE Admin

Industry Experts, a multi industry focused market research firm, has today announced the availability an exclusive a research report on Synthetic Vitamin E market. The new report ‘Synthetic Vitamin E – A Global Market Overview’ reveals that the global consumption of synthetic vitamin E, in terms of volume stood at 100.3 thousand metric tons valued at US$1.06 million in 2012, is further expected to maintain a volume CAGR of 4.2% between 2012 and 2020 to reach a projected 139.1 thousand metric tons in 2020, while value CAGR is anticipated to be 5.2% over the same period that would enable in boosting up demand for synthetic vitamin E to US$1.6 billion in 2020.

An increasing demand for livestock directly translates into increasing demand for animal feed and animal feed additives such as vitamins. Synthetic vitamin E is the key ingredient used in global animal feed industry today. It is obvious that demand for synthetic vitamin E for animal feed applications would continue to grow as demand for livestock also grows, more so in the developing regions of Asia, Africa and Latin America. Countries, such as Brazil, China, Russia and other Asian and African regions have been on a catching up mode as they are increasingly adopting modern animal production systems to keep abreast of enhancing domestic demand.

Animal feed is the largest application area with a volume share of about 81.9%, translating into 82.1 thousand metric tons, and value share of 67.1% equating to US$712.9 million in 2012. Further, consumption of synthetic vitamin E by the animal feed industry is also expected to record the fastest 2012-2020 CAGR of 4.5% in reaching a projected 116.5 thousand metric tons in 2020 in terms volume and projected to reach US$1.1 billion by 2020 at a CAGR of 5.7% over 2012-2020 in terms of value.

The synthetic vitamin E growth in animal feed industry is mainly attributed to the animal feed industry’s growth in developing world. The demand for livestock products such as meat, poultry etc. is increasing rapidly in developing nations. The main attributes for this growth would be population growth, urbanization and especially growing household incomes in these countries. General patterns of food consumption and specific demand for livestock products are greatly shaped by levels of urbanization and growth in income. As a consequence, these developing nations are the regions slated to emerge as the fastest growing for food products derived from livestock.

The report reviews, analyses and projects the synthetic vitamin E market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for independent countries across North America – The United States, Canada and Mexico; Europe – Germany, France, Italy, Spain, The United Kingdom, The Netherlands and Rest of Europe; Asia-Pacific – China, Japan and Rest of Asia-Pacific. Synthetic vitamin E end-use applications covered in this report include animal feed, dietary supplements, food & beverages and cosmetics.

The study includes 95 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global synthetic vitamin E market value in metric tons and value in US$ by geographic region and end-use application. This study profiles 6 key global players and 15 major players across Europe – 3; Asia-Pacific – 11 and Rest of World – 1. The report also provides the listing of the companies engaged in the manufacturing and supply of synthetic vitamin E as well as major players in vitamin E end-use industries such as human nutrition, animal nutrition and personal care. The global list of companies covers addresses, contact numbers and the website addresses of 107 companies.

For more details, please visit http://industry-experts.com/verticals/general/synthetic-vitamin-E-a-global-market-overview.html

tags: , , , , ,

50 Comments »

01 Jul

Global Consumption of Natural Vitamin-E is to Reach 18k MTs by 2020

Posted in General Reports, News on 01.07.13 by IE Admin

Industry Experts, a multi industry focused market research firm, has today added the industry’s first and only exclusive a research report on Natural Vitamin E market. The new report ‘Natural Source Vitamin E (Tocopherols and Tocotrienols) – A Global Market Overview’ reveals that the global market for Natural Vitamin E is estimated at US$611.9 million in 2013 and set to cross the US$1 billion mark by 2019.
Natural Source Vitamin E, an important fat-soluble antioxidant that helps fight free-radicals, offers a two-fold bioavailability and can be preserved longer by the body tissues when compared to synthetic vitamin E. Moreover, products and ingredients such as vitamins that carry the “Natural” tag have been garnering increased consumer demand and becoming important considerations. Concerns relating to toxic chemical additives by the consumers in products such as food, beverages and personal care are fueling the rapid growth in sales of natural vitamin E. Nutritional supplements followed by food & beverage fortification being the current primary markets for natural vitamin E, cosmetics and animal nutrition are projected to be the promising markets in the near future.
Natural vitamin E market has been experiencing a major imbalance in supply and demand from past few years as the prices of natural vitamin E have been witnessed a substantial increase due to the several unifying factors. One important reason cited for this spike in prices has been the supply shortage of the primary raw material, deodorized distillates, that goes into manufacturing natural vitamin E. Players in the natural vitamin E space are in the process of scrutinizing alternative means of production that could offset the supply-demand imbalance, though nothing concrete seems to have come up for generating an added supply in the future. While a few companies are aiming to bypass the issue of supply, yet others are exploring alternate sources such as deodorized distillates from rapeseed, palm oils and mixed sources to extract natural vitamin E.
Natural source Vitamin E products analyzed in this study include Tocopherols and Tocotrienols. The end use application markets covered in the report include Animal Feed, Nutritional/Dietary Supplements, Food & Beverages and Cosmetics. The report reviews, analyses and projects the natural source vitamin E market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for independent countries across North America – The United States and Rest of North America; Europe – Germany, France, Italy, Spain, The United Kingdom, The Netherlands and Rest of World; Asia-Pacific – China, Japan and Rest of Asia-Pacific.
Global volume consumption of natural source vitamin E stood at 10.3 thousand metric tons in 2012, is estimated at 10.9 thousand metric tons in 2013 and projected to be 18.1 thousand metric tons in 2020, thereby exhibiting a CAGR of 7.3% between 2012 and 2020.
The study includes 228 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value in metric tons and value in US$ by geographic region, the product segment and application area. This study profiles 19 key global players and 40 major players across North America – 5; Europe – 4; Asia-Pacific – 30 and Rest of World – 1. The report also provides the listing of the companies engaged in the manufacturing and supply of natural vitamin E as well as major players in the vitamin E end-use industries such as human nutrition, animal nutrition and personal care. The global list of companies covers addresses, contact numbers and the website addresses of 152 companies.

For more details, please visit http://industry-experts.com/verticals/general/natural-source-vitamin-E-tocopherols-and-tocotrienols-a-global-market-overview.html

tags: , , , , , , , , , , , , , , , , , , , ,

54 Comments »